These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 19249989)
1. An extreme strategy for the production of hybridoma. Golestani R; Pourfathollah AA; Moazzeni SM Hybridoma (Larchmt); 2009 Apr; 28(2):139-44. PubMed ID: 19249989 [TBL] [Abstract][Full Text] [Related]
2. Cephalin as an efficient fusogen in hybridoma technology: can it replace poly ethylene glycol? Golestani R; Pourfathollah AA; Moazzeni SM Hybridoma (Larchmt); 2007 Oct; 26(5):296-301. PubMed ID: 17979545 [TBL] [Abstract][Full Text] [Related]
3. A human anti-Jkb monoclonal antibody. Lecointre-Coatmelec M; Bourel D; Ferrette J; Genetet B Vox Sang; 1991; 61(4):255-7. PubMed ID: 1663674 [TBL] [Abstract][Full Text] [Related]
4. Establishment of hybridoma secreting human monoclonal antibody against hepatitis B virus surface antigen. Ichimori Y; Harada K; Hitotsumachi S; Tsukamoto K Biochem Biophys Res Commun; 1987 Feb; 142(3):805-12. PubMed ID: 3030301 [TBL] [Abstract][Full Text] [Related]
5. Rescue of human monoclonal antibody production from an EBV-transformed B cell line by fusion to a human-mouse hybridoma. Foung SK; Perkins S; Raubitschek A; Larrick J; Lizak G; Fishwild D; Engleman EG; Grumet FC J Immunol Methods; 1984 May; 70(1):83-90. PubMed ID: 6201562 [TBL] [Abstract][Full Text] [Related]
6. Establishment of human heterohybridoma and lymphoblastoid cell lines specific for the Rh D and C antigens. Pasha RP; Roohi A; Shokri F Transfus Med; 2003 Apr; 13(2):83-92. PubMed ID: 12694553 [TBL] [Abstract][Full Text] [Related]
7. Human monoclonal antibody to purified protein derivative of tuberculin produced by hybrids constructed with Epstein-Barr virus-transformed B lymphocytes and mouse myeloma cells. Garzelli C; Puglisi C; Falcone G Eur J Immunol; 1986 May; 16(5):584-7. PubMed ID: 3009205 [TBL] [Abstract][Full Text] [Related]
8. Increased human hybridoma formation by electrofusion of human B cells with heteromyeloma SPAM-8 cells. Panova I; Gustafsson B Hybridoma; 1995 Jun; 14(3):265-9. PubMed ID: 7590790 [TBL] [Abstract][Full Text] [Related]
9. SPAM-8, a mouse-human heteromyeloma fusion partner in the production of human monoclonal antibodies. Establishment of a human monoclonal antibody against cytomegalovirus. Gustafsson B; Jondal M; Sundqvist VA Hum Antibodies Hybridomas; 1991 Jan; 2(1):26-32. PubMed ID: 1651784 [TBL] [Abstract][Full Text] [Related]
10. Human anti-tetanus toxoid monoclonal antibody secreted by EBV-transformed human B cells fused with murine myeloma. Kozbor D; Roder JC; Chang TH; Steplewski Z; Koprowski H Hybridoma; 1982; 1(3):323-8. PubMed ID: 6092264 [TBL] [Abstract][Full Text] [Related]
11. The construction and use of a human-mouse myeloma analogue suitable for the routine production of hybridomas secreting human monoclonal antibodies. Posner MR; Elboim H; Santos D Hybridoma; 1987 Dec; 6(6):611-25. PubMed ID: 3436625 [TBL] [Abstract][Full Text] [Related]
12. The generation of hybridomas secreting human monoclonal antibodies reactive with type II collagen. Posner MR; Barrach HJ; Elboim HS; Nivens K; Santos DJ; Chichester CO; Lally EV Hybridoma; 1989 Apr; 8(2):187-97. PubMed ID: 2541068 [TBL] [Abstract][Full Text] [Related]
13. [A strategy for the production of human monoclonal antibodies]. Chiba J Hum Cell; 1988 Mar; 1(1):31-6. PubMed ID: 2856441 [TBL] [Abstract][Full Text] [Related]
14. High-resolution analysis of the B cell repertoire before and after polyethylene glycol fusion reveals preferential fusion of rare antigen-specific B cells. Dubois AR; Buerckert JP; Sinner R; Faison WJ; Molitor AM; Muller CP Hum Antibodies; 2016 Jun; 24(1-2):1-15. PubMed ID: 27472868 [TBL] [Abstract][Full Text] [Related]
15. Hybridoma technologies for antibody production. Tomita M; Tsumoto K Immunotherapy; 2011 Mar; 3(3):371-80. PubMed ID: 21395379 [TBL] [Abstract][Full Text] [Related]
16. [Obtention of a heterohybridoma for production of type IgM monoclonal antibodies against the D antigen of the Rh system]. León-González G; Cruz C Invest Clin; 2007 Mar; 48(1):57-67. PubMed ID: 17432544 [TBL] [Abstract][Full Text] [Related]
17. Human T cell hybridomas specific for Epstein Barr virus-infected B lymphocytes. Lakow E; Tsoukas CD; Vaughan JH; Altman A; Carson DA J Immunol; 1983 Jan; 130(1):169-72. PubMed ID: 6292301 [TBL] [Abstract][Full Text] [Related]
18. The hybridization of EBV-immortalized human B-lymphocytes with a human-mouse heteromyeloma cell line. Jahn S; Walper A; Grunow R; Heym S; Volk HD; von Baehr R Allerg Immunol (Leipz); 1990; 36(4):359-65. PubMed ID: 1965878 [TBL] [Abstract][Full Text] [Related]
19. Characterization of stable Epstein-Barr (EB) virus transformed cell lines and mouse-human hybridomas producing a large quantity of anti-tetanus toxoid (TT) monoclonal antibody. Minakawa H; Hirata Y; Sugawara I; Fukuda A; Yoshida TO Behring Inst Mitt; 1985 Dec; (78):139-47. PubMed ID: 3008706 [TBL] [Abstract][Full Text] [Related]
20. Production of anti-tumor human monoclonal antibodies using different approaches. Liu H; Xu ZL; Wang Y; Yang L; Feng O; Li Y; Wang YM; Zhang GG Hum Antibodies Hybridomas; 1993 Jan; 4(1):2-8. PubMed ID: 8381684 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]